NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Creative Biosciences (Guangzhou) Co., Ltd.

Creative Biosciences (Guangzhou) Co., Ltd.

Private
GuangzhouHealthcare & Life Scienceshttps://www.creativebio.cn/

Last Round

Series D

Oct 20, 2021

Total Funding Raised

$223.52M

Company Overview

Creative Biosciences (Guangzhou) Co., Ltd. is a biotechnology company that specializes in the development and manufacturing of non-invasive cancer detection kits and point-of-care testing (POCT) products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

cancer detectioncolorectal cancer screeningnoninvasive diagnosticsliquid biopsyDNA methylation testmolecular diagnosticsdiagnostic reagent kitearly cancer screeninglaboratory automationclinical diagnosticspoint of care testingPOCTmicrofluidic qPCRnucleic acid extractioncoagulation analyzer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Creative Biosciences (Guangzhou) Co., Ltd. Comparables

Compare Creative Biosciences (Guangzhou) Co., Ltd. with similar companies based on industry and business-model similarity.

Creative Biosciences (Guangzhou) Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wuhan Ammunition Life-tech Co., Ltd.
85%
New Horizon Health
83%
Shanghai Realbio Technology Co., Ltd.
83%

Creative Biosciences (Guangzhou) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DOct 20, 2021
Series CSep 27, 2020
StrategicAug 1, 2019
Series BApr 12, 2019
VC RoundJun 1, 2016
Pre Seed
Jul 1, 2015

Creative Biosciences (Guangzhou) Co., Ltd. Investors

Notable investors and investment history

Creative Biosciences (Guangzhou) Co., Ltd. investors
InvestorRounds
Linden AssetSeries C
IDG CapitalSeries D, Series B, Series C
Agricultural Bank of China InternationalSeries D
Bohai Industrial Investment Fund Management Co., Ltd.Series A
健壹资本Strategic
Oceanpine CapitalSeries C
Guangzhou Financial Holdings Fund ManagementSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 27, 2020

    $88M round with participation from CDH Investments and IDG Capital.

  • Apr 12, 2019

    $45M round with CDH Investments, CD Capital, and IDG Capital.

Creative Biosciences (Guangzhou) Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Creative Biosciences (Guangzhou) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Creative Biosciences (Guangzhou) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGuangzhou
Employee Range21
Year Founded2015
Last FundingOct 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.